Get the latest industry news first when you subscribe to our daily newsletter.
We will never sell or share your information without your consent. See our privacy policy.
April 29, 2021
April 29, 2021 | Illumina joins the Gates Foundation in a global pathogen genomics initiative, new money for immune profiling, and Benchling nets $200M for their cloud platform.
$375M: Fund for Growth-Stage Medtech, Digital Health
Endeavour Vision has closed Endeavour Medtech Growth II (EMG II) LP at USD 375 million in capital commitments. The fund will pursue the same strategy as its predecessor: to support growth-stage medtech and digital health innovations that advance the standard of care and bring efficiencies to healthcare systems. Both new and returning investors supported EMG II LP, including public pension funds, multi-manager funds, family offices, and high-net-worth individuals. EMG II LP builds on Endeavour Vision’s two decades of healthcare investing, which to date has included over USD 500 million invested in 42 companies 21 of which have exited via an acquisition or IPO. The fund has already supported seven companies with investm
Gina Biachinin s Mighty Networks scores $50M to help creators and brands grow communities bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
Willow Raises Additional $26.8M in Series C Extention Funding
Willow, a Mountain View, Calif.-based FemTech company, raised an additional $26.8M in funding through a Series C extension round.
The round was led by Endeavour Vision, alongside NEA (New Enterprise Associates), Pura Vida Investments, Purple Arch Ventures (a part of Alumni Ventures Group), Logos Capital, and Gaingels. This extension brings Willow’s total Series C investment to $81.8M.
The company intends to use the funds to invest in new products, further expand its reach internationally presence, and grow brand awareness.
Led by CEO Laura Chambers, Willow is a provider of an in-bra wearable breast pump with full spill-proof mobility. The Willow Wearable Breast Pump features innovative technology that enables total spill-proof mobility while pumping, ditching long tubes, cords, dangling bottles and loud sucking sounds so moms can pump wherever their day takes them.
Endeavour Vision Closes Endeavour Medtech Growth II, at USD375M
Endeavour Vision, a venture capital and growth equity firm, closed the Endeavour Medtech Growth II (EMG II) LP fund, at USD 375m.
Both new and returning investors supported EMG II LP, including public pension funds, multi-manager funds, family offices and high-net-worth individuals.
Led by managing partners Bernard Vogel or Damien Teppy, Endeavour Medtech Growth II (EMG II) LP will invest in growth-stage medtech and digital health innovations that advance the standard of care and bring efficiencies to healthcare systems.
The fund’s closing comes as the world begins to look towards post-pandemic life after more than 12 months in the grip of COVID-19, a crisis that has accelerated the adoption of new healthcare technologies including novel ways of delivering remote patient care. Underlying trends, such as ageing populations, chronic diseases and strained healthcare budgets will continue to fuel demand for cost-ef